These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4424380)

  • 1. [Test methods for the indication and control of platelet aggregation inhibitors].
    Linker H; Loew D; Krenkel W; Bröcheler HL; Reuter H
    Med Welt; 1974 Jun; 25(25):1124-6. PubMed ID: 4424380
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with the platelet aggregation inhibitor Colfarit in thromboembolic diseases in general practice].
    Sellier W
    Med Welt; 1971 Dec; 50():2013-4. PubMed ID: 5134751
    [No Abstract]   [Full Text] [Related]  

  • 3. Status of platelet functions in volunteers of various blood groups: effect of aspirin.
    Sudhir S; Gupta LC; Singh J; Garg KN
    Indian J Physiol Pharmacol; 1984; 28(2):137-40. PubMed ID: 6511062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: Inhibition of human platelet aggregation by aspirin in vitro and ex vivo.
    Gordon JL; Macintyre DE
    Br J Pharmacol; 1974 Nov; 52(3):451P. PubMed ID: 4458864
    [No Abstract]   [Full Text] [Related]  

  • 5. [Secondary prevention of coronary disease with platelet aggregation inhibiting drugs. Preliminary report].
    Caruzzo C; Belli R; Biasci R; Gaschino G; Bruna C
    Minerva Cardioangiol; 1979 Jun; 27(6):367-72. PubMed ID: 38413
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin in the prophylaxis of venous and arterial diseases.
    Loew D
    Proc R Soc Med; 1977; 70 Suppl 7(Suppl 7):28-31. PubMed ID: 615313
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute effect of ethanol administration on platelet function.
    Sudhir S; Gupta LC; Singh J; Budhiraja RD
    Indian J Physiol Pharmacol; 1987; 31(4):240-4. PubMed ID: 3450629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of aspirin in ischemic heart disease].
    Frishman W; Horwitz S
    Arch Inst Cardiol Mex; 1977; 47(2):129-31. PubMed ID: 901049
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inhibition of platelet adhesiveness and aggregation and protection against cerebral ischemic anoxia by aspirin and 1520 RB. Animal studies].
    Reynier M; Monnier G; Eyraud H; Dubreuil J; Journeau G; Roquet F
    Agressologie; 1977; 18(6):315-24. PubMed ID: 613846
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Investigations in animal experiments regarding the mechanism of action of acetylsalicylic acid (ASA) as an inhibition of platelet aggregation.
    Seuter F
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R60. PubMed ID: 1143466
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of salicylic acid and pyridinolcarbamate on the platelet aggregation (author's transl)].
    Altman R; Rouvier J; Taboada S; Mosquera G
    Sangre (Barc); 1974; 19(4):385-98. PubMed ID: 4445961
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the inhibition of blood platelet aggregation and adhesiveness by 2 soluble derivatives of acetylsalicylic acid].
    Prost-Dvojakovic RJ; Lecrubier C; Samama M
    Therapie; 1975; 30(1):137-48. PubMed ID: 1135777
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetylsalicylic acid, hemostasis and human thromboembolism.
    Jobin F
    Semin Thromb Hemost; 1978; 4(3):199-240. PubMed ID: 204999
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the results obtained in thromboembolic vascular lesions with 2 platelet aggregation inhibitors].
    Parisi FR; Raso AM; Fiorio C; Salvetti M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1983; 32(4):293-6. PubMed ID: 6150522
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of thromboembolic processes using acetylsalicylic acid. Action mechanism and clinical aspects].
    Scharrer I
    Radiologe; 1971 Nov; 11(11):426-8. PubMed ID: 5136342
    [No Abstract]   [Full Text] [Related]  

  • 16. [Should all prosthetic valve patients be treated by platelet inhibitors?].
    Lévy G; Bordes F; Mariottini P; François G
    Nouv Presse Med; 1976 Jan; 5(5):251-4. PubMed ID: 1264682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of platelet aggregation with acetylsalicylic acid. Experimental and clinical results].
    Breddin K; Scharrer I; Schepping M
    Munch Med Wochenschr; 1971 Oct; 113(40):1284-92. PubMed ID: 5171107
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspirin resistance: focus on clinical endpoints.
    Pusch G; Feher G; Kotai K; Tibold A; Gasztonyi B; Feher A; Papp E; Lupkovics G; Szapary L
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):475-84. PubMed ID: 19034037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin resistance: current concepts.
    Mason PJ; Freedman JE; Jacobs AK
    Rev Cardiovasc Med; 2004; 5(3):156-63. PubMed ID: 15346099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acetylsalicylic acid in the prevention and therapy of thrombotic diseases. Theoretical findings and prospects].
    Weber E
    Med Welt; 1975 Aug; 6(35):1493-8. PubMed ID: 1177739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.